Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT05729555
Ignite Creation Date: 2024-05-06 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05729555
Protocol Section: NCT05729555
Start Identification Module Data
Expand Identification Module Data
Brief Title: Comparative Pharmacokinetic PK Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition
Official Title: An Open Label Balanced Randomized Single-dose Two-treatment Two-sequence Two-period Two-way Crossover Oral Comparative Pharmacokinetic PK Study of Ibuprofen and Diphenhydramine Hydrochloride Modified-Release Tablets 400mg50mg of Overseas Pharmaceuticals Ltd With Motrin IB Ibuprofen Tablets USP 200mg 2 200mg and BENADRYL Diphenhydramine Hydrochloride Tablet 25 mg225 mg Distributed by - Johnson Johnson Consumer Inc McNeil Consumer Healthcare Division in Normal Healthy Adult Human Subjects Under Fasting Condition
Acronym: None
Organization: Overseas Pharmaceuticals Ltd
Organization Class: INDUSTRY
Organization Study ID: YYKQ-202210
Start Status Module Data
Status Verified Date: 2023-02
Overall Status: NOT_YET_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Overseas Pharmaceuticals Ltd
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Overseas Pharmaceuticals Ltd
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload